Vanke Co., Ltd 2025 Annual Independent Directors' Work Report (Zhang Yichen)
As an independent director of Vanke Enterprise Co., Ltd. (hereinafter referred to as the "Company"), I am responsible for the "Public" in accordance with the "Public." Judicial, Measures for the Administration of Independent Directors of Listed Companies, and the relevant laws and regulations of Vanke Co., Ltd The company has been diligent in performing its duties and effectively safeguarding the overall company as stipulated in the Articles of Association (hereinafter referred to as the "Articles of Association"). and the legitimate rights and interests of all shareholders, especially minority shareholders. Here, I am presenting my information from January 2025 to 2025 The main report on the performance of independent director duties in December (hereinafter referred to as the "term of office") is as follows:
- Personal Basic Information (1) Personal Resume
Since July 2020, I have served as an independent director and investment director of the 19th and 20th boards of directors of the company Convener of the Decision Committee. I am currently the Chairman and CEO of CITIC Capital Holdings Limited. Myself Graduated from MIT in 1986 with a bachelor's degree in computer science. I have been here since 1987 In 2000, he worked at Greenwich Capital Markets and served as a securities advisor at the New York branch of Bank of Tokyo Head of business transactions, Head of Bond Capital Markets for Merrill Lynch Greater China, etc. I added it in 2000 Joined CITIC Group, serving as Executive Director of CITIC Pacific and CITIC Pacific Information Technology Co., Ltd. from 2000 to 2002 Company president; In 2002, participated in the establishment of CITIC Capital Holdings Limited (hereinafter referred to as "CITIC Capital"), He currently serves as Chairman and CEO of CITIC Capital. Currently, I am still investing in some companies invested in by CITIC Capital He also held directorship positions, such as Grand Foods Holdings Limited (McDonald's China mainland and Xiang). Hong Kong franchisee) Chairman of the Board and Chairman of Harbin Pharmaceutical Group Co., Ltd., currently also serving as Hong Kong Trading Partner and Clearing Limited (a company listed on the Hong Kong Stock Exchange, stock code: 0388) as an independent director. I am ranked tenth Member of the 1st, 12th, 13th, and 14th National Committee of the Chinese People's Political Consultative Conference. I previously worked at General Global Medical Group Co., Ltd. (Joint Association). Listed on the Stock Exchange, stock code: 2666), Chairman of the Board, Harbin Pharmaceutical Group Co., Ltd. (Shanghai Stock Exchange). Listed company, stock code: 600664) Chairman, SF Holding Co., Ltd. (listed on the Shenzhen Stock Exchange). The company, stock code: 002352) director, AsiaInfo Technologies Holdings Limited (a company listed on the Stock Exchange, shares). Code: 1675) Directors, etc.
1
(2) Independence
I am qualified to be listed in the "Measures for the Administration of Independent Directors of Listed Companies" and the "Securities Registration Measures of The Stock Exchange of Hong Kong Limited." and the Articles of Association as required by the Articles of Association and other laws, and the company's articles of association, and have carried out independent regulations in accordance with regulatory rules Self-examination of character is established; there is no situation that affects independence. As an independent director of the company, I do not concurrently serve in the company Other positions other than members of the board's professional committees have no direct or indirect relationship with the company or its major shareholders Interests or other relationships that may hinder the principal's independent and objective judgment, performing duties independently, no
Affected by the company and its major shareholders or other entities or individuals. 2. Performance of duties (1) Board of Directors and Shareholders' Meeting